Tweets
Photovoice: A New Visual Research Method in Lupus
Dr. Bella Mehta ( @bella_mehta) talks with Dr. Candace Feldman about Abstract 1099: Empowering Patients with Lupus Through Their Photographs at #ACR22.
https://t.co/tPizbi16Om https://t.co/lYUXaGEerA
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
Is toci an option in refractory PMR? #ACR22
📍double-blind RCT
💪101 pts w/GC-resistant PMR (mod. dz on pred. < 10 mg)
💉toci 8 mg/kg q4w + pred taper vs. placebo + pred taper over 24w
🌟49% in toci group stopped pred at week 24 vs. 20% in placebo
🌟AE similar b/t groups
Catherine Sims, MD @DrCassySims ( View Tweet )
3 years 7 months ago
Just accepted in Arthritis & Rheumatology:
Incidence, Prevalence, and Mortality of Lupus Nephritis: A Population-Based Study Over Four Decades—The Lupus Midwest Network (LUMEN)
https://t.co/StigaFb3YZ
ACR_Journals @ACR_Journals ( View Tweet )
3 years 7 months ago
Impact of COVID 19 on Pregnancies in Women with RMD
Dr. Cassy Sims ( @DrCassySims) discusses abstract 0950 at #ACR22.
https://t.co/qbFRV5P3eP https://t.co/cmS4n15L5e
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
What lifestyle factors affect TNF inhibitor efficacy in AxSpA?
Dr Chao ( @doctorRBC) discusses Abstract 1510 at #ACR22 . Abstract 1510: Modifying Lifestyle Factors May Offer the Potential to Enhance the Outcome of TNF Inhibitors in AxSpA
https://t.co/h8ZniRF5rO https://t.co/SZq5bvYPzt
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
RA-ILD: an update
Dr. Julian Segan ( @JulianSegan) discusses Abstract #1393 and Abstract #0245 presented at #ACR22.
https://t.co/5Vk4NaWzqc https://t.co/doqhqeNgdX
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
Are MDA criteria created equal in PsA?
Dr. Rachel Tate ( @uptoTate ) reviews abstract #1496: Do Patients in MDA Report Low Disease Activity Regardless of Which of the MDA Criteria Are Met?
Presented at #ACR22.
https://t.co/H4wPHEV8D5 https://t.co/NqXYxXRNEX
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
Where are we with treating Pre-Rheumatoid Arthritis?
Dr. Richard Conway ( @RichardPAConway ) discusses abstracts #0530, #1603 and #1604 shared at #ACR22.
https://t.co/zWTFMgSmvA https://t.co/DYRUI4gfNU
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
Are we really treating Psoriatic disease if we only address active disease domains and T2T?
Dr. Rachel Tate ( @uptotate) breaks down abstracts #0393 and #0387 and how the takeaways will apply to her practice.
https://t.co/OrNZVUuvBZ https://t.co/UL4Hscjs4Z
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
Spondyloarthritis Topic Panel - #ACR22
SpA Panelists: Drs. Lianne Gensler, Antoni Chan, Akhil Sood, Eric Dein, Sheila Reyes, Catherine Sims
@synovialjoints @AkhilSoodMD @ericdeinmd @RHEUMarampa @DrCassySims
https://t.co/No1AfHQf3k https://t.co/F9SHCOwwHC
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
Women vs. Men: Response to Treatment in Seronegative Arthritis
Dr. Janet Pope ( @Janetbirdope) discusses abstracts 1614 and 1601 at #ACR22
https://t.co/9Safzla7OK https://t.co/cw6eoFBN58
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
Switch vs Cycle in PsA
Dr. Arthur Kavanaugh discusses abstract 1600 at #ACR22
https://t.co/RkXvuGvvGU https://t.co/nDiWg6dgWM
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
